Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,004 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo.
Kahn RS, Westenberg HG, Verhoeven WM, Gispen-de Wied CC, Kamerbeek WD. Kahn RS, et al. Int Clin Psychopharmacol. 1987 Jan;2(1):33-45. doi: 10.1097/00004850-198701000-00003. Int Clin Psychopharmacol. 1987. PMID: 3312397 Clinical Trial.
The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia.
Scheepers FE, Gespen de Wied CC, Kahn RS. Scheepers FE, et al. Among authors: kahn rs. J Clin Psychopharmacol. 2001 Dec;21(6):575-82. doi: 10.1097/00004714-200112000-00006. J Clin Psychopharmacol. 2001. PMID: 11763004 Clinical Trial.
Effects of ipsapirone in healthy subjects: a dose-response study.
Kahn RS, Trestman R, Lawlor BA, Gabriel S, Davidson M, Siever L. Kahn RS, et al. Psychopharmacology (Berl). 1994 Feb;114(1):155-60. doi: 10.1007/BF02245457. Psychopharmacology (Berl). 1994. PMID: 7846198 Clinical Trial.
The MCPP challenge test in schizophrenia: hormonal and behavioral responses.
Iqbal N, Asnis GM, Wetzler S, Kahn RS, Kay SR, van Praag HM. Iqbal N, et al. Among authors: kahn rs. Biol Psychiatry. 1991 Oct 15;30(8):770-8. doi: 10.1016/0006-3223(91)90233-c. Biol Psychiatry. 1991. PMID: 1751620 Clinical Trial.
Psychopharmacology of anxiety disorders: on the role of serotonin in the treatment of anxiety states and phobic disorders.
Westenberg HG, den Boer JA, Kahn RS. Westenberg HG, et al. Among authors: kahn rs. Psychopharmacol Bull. 1987;23(1):145-9. Psychopharmacol Bull. 1987. PMID: 3110855 Clinical Trial. No abstract available.
L-5-hydroxytryptophan in depression and anxiety.
van Praag HM, Kahn RS. van Praag HM, et al. Among authors: kahn rs. Schweiz Rundsch Med Prax. 1988 Aug 23;77(34A):40-6. Schweiz Rundsch Med Prax. 1988. PMID: 3055148 Review. No abstract available.
Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine.
den Boer JA, Westenberg HG, Kamerbeek WD, Verhoeven WM, Kahn RS. den Boer JA, et al. Among authors: kahn rs. Int Clin Psychopharmacol. 1987 Jan;2(1):21-32. doi: 10.1097/00004850-198701000-00002. Int Clin Psychopharmacol. 1987. PMID: 3117876 Clinical Trial.
L-5-hydroxytryptophan in the treatment of anxiety disorders.
Kahn RS, Westenberg HG. Kahn RS, et al. J Affect Disord. 1985 Mar-Apr;8(2):197-200. doi: 10.1016/0165-0327(85)90046-1. J Affect Disord. 1985. PMID: 3157732
Serotonin and anxiety revisited.
Kahn RS, van Praag HM, Wetzler S, Asnis GM, Barr G. Kahn RS, et al. Biol Psychiatry. 1988 Jan 15;23(2):189-208. doi: 10.1016/0006-3223(88)90091-1. Biol Psychiatry. 1988. PMID: 3275471 Review. No abstract available.
Behavioral indications for serotonin receptor hypersensitivity in panic disorder.
Kahn RS, Wetzler S, van Praag HM, Asnis GM, Strauman T. Kahn RS, et al. Psychiatry Res. 1988 Jul;25(1):101-4. doi: 10.1016/0165-1781(88)90163-1. Psychiatry Res. 1988. PMID: 3217461
1,004 results
Jump to page
Feedback